SWK Holdings Corp (SWKHL)
2025-06-30 | ||||
---|---|---|---|---|
Total revenues | 10,052 | |||
Pharmaceutical manufacturing, research and development expense | 645 | |||
Provision (benefit) for credit losses | 761 | |||
Interest expense | 1,155 | |||
Loss on impairment of intangibles assets | - | |||
General and administrative expense | 2,843 | |||
Depreciation and amortization expense | 19 | |||
Change in fair value of acquisition-related contingent consideration | - | |||
Income from operations | 4,629 | |||
Net gain (loss) on marketable investments | 37 | |||
Realized gain on early payment of finance receivable | - | |||
Loss on sale of assets | - | |||
Realized and unrealized foreign currency transaction gains (losses) | -451 | |||
Gain (loss) on revaluation of finance receivables | - | |||
Net gain on exercise and cancellation of warrants | - | |||
Unrealized net gain (loss) on warrants | 347 | |||
Income before income tax expense | 4,562 | |||
Income tax expense | 1,026 | |||
Net income | 3,536 | |||
Basic (in dollars per share) | 0.29 | |||
Basic (in shares) | 12,208,000 | |||
Diluted (in dollars per share) | 0.29 | |||
Diluted (in shares) | 12,208,000 |